Compare UG & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UG | NMTC |
|---|---|---|
| Founded | 1942 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2M | 42.6M |
| IPO Year | 1995 | 2010 |
| Metric | UG | NMTC |
|---|---|---|
| Price | $6.68 | $0.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.98 |
| AVG Volume (30 Days) | 3.4K | ★ 221.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.63% | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $12,181,971.00 | $9,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.17 |
| P/E Ratio | $32.75 | ★ N/A |
| Revenue Growth | 11.91 | ★ 163.47 |
| 52 Week Low | $5.58 | $0.40 |
| 52 Week High | $10.09 | $1.15 |
| Indicator | UG | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 49.00 |
| Support Level | $6.31 | $0.69 |
| Resistance Level | $6.75 | $0.89 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 40.00 | 46.72 |
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.